Congenital Amegakaryocytic Thrombocytopenia—3 Novel c-MPL Mutations and Their Phenotypic Correlations
Authors:
- Gil GiladGGGil Gilad
- Orly DganyODOrly Dgany
- Tatyana KrasnovTKTatyana Krasnov
- Meira ZoldanMZMeira Zoldan
- Ruth LaorRLRuth Laor
- Joseph KapelushnikJKJoseph Kapelushnik
- Herzel GabrielHGHerzel Gabriel
- Chaim ChuriCCChaim Churi
- Jerry SteinJSJerry Stein
- Isaac YanivIYIsaac Yaniv
- Hannah TamaryHTHannah Tamary
- 1 December 2007
- journal article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 29 (12) , 822-825
Abstract
Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare bone marrow failure syndrome associated with thrombocytopenia and a tendency to progress to aplastic anemia. Mutations in the c-MPL gene encoding for thrombopoietin receptor have been identified in the majority of the patients. Previous studies suggest a genotype-phenotype correlation wherein the severity of the disease depends on the type of mutation present and residual thrombopoietin receptor activity. The present study describes the clinical and genetic findings on a series of 7 patients with CAMT, 3 of them siblings. The patients were homozygous for 5 mutations in the c-MPL gene, including 3 unique ones: c.212+5G>A, C76T, and G1162C. The clinical picture was variable; 1 patient who was homozygous for a nonsense mutation in exon 1 (C76T) developed infantile acute lymphoblastic leukemia, whereas patients who were homozygous for a splice-site mutation (c.212+5G>A) expressing both normal and mutated transcripts had a milder clinical course. As previously suggested, c-MPL mutation analysis in CAMT patients helps to predict the clinical course and to provide optimal therapy.Keywords
This publication has 15 references indexed in Scilit:
- MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the diseaseHuman Mutation, 2006
- Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patientsBritish Journal of Haematology, 2005
- Molecular characterization of three novel Fanconi anemia mutations in Israeli ArabsEuropean Journal of Haematology, 2004
- Thrombopoietin Is Essential for the Maintenance of Normal Hematopoiesis in HumansAnnals of the New York Academy of Sciences, 2003
- c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopeniaBlood, 2001
- Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopeniaBritish Journal of Haematology, 2000
- Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopeniaProceedings of the National Academy of Sciences, 1999
- Ability of Early Acting Cytokines to Directly Promote Survival and Suppress Apoptosis of Human Primitive CD34+CD38− Bone Marrow Cells With Multilineage Potential at the Single-Cell Level: Key Role of ThrombopoietinBlood, 1997
- Defective response to thrombopoietin and impaired expression of c‐mpl mRNA of bone marrow cells in congenital amegakaryocytic thrombocytopeniaBritish Journal of Haematology, 1997
- Congenital Amegakaryocytic ThrombocytopeniaJournal of Pediatric Hematology/Oncology, 1990